Literature DB >> 20798240

Remission in CML: is DNA useful?

François-Xavier Mahon1.   

Abstract

Entities:  

Year:  2010        PMID： 20798240     DOI： 10.1182/blood-2010-05-286310

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation.

Authors:  Koichi Miyamura; Kazunori Ohnishi; Shigeki Ohtake; Noriko Usui; Chiaki Nakaseko; Hiroyuki Fujita; Shin Fujisawa; Toru Sakura; Hirokazu Okumura; Noriyoshi Iriyama; Nobuhiko Emi; Katsumichi Fujimaki; Sumihisa Honda; Yasushi Miyazaki; Tomoki Naoe
Journal:  Blood Adv       Date:  2019-02-12

2.  Mapping of apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy.

Authors:  Jaganmohan R Jangamreddy; Soumya Panigrahi; Kourosh Lotfi; Manisha Yadav; Subbareddy Maddika; Anil Kumar Tripathi; Sabyasachi Sanyal; Marek J Łos
Journal:  Oncotarget       Date:  2014-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.